Neurogranin has already been established as a sensitive marker of synaptic degeneration in Alzheimer’s disease, and its altered dynamics after mTBI may represent a mechanistic link between acute synaptic injury and later-life cognitive decline. Here, NRGN is linked to Alzheimer disease.